Stock Under $10 with 50-100% upside potential - 14 Days FREE!

CareFusion Expands Infusion Pump Interoperability

Stock quotes in this article: CFN 

SAN DIEGO, June 20, 2012 /PRNewswire/ -- CareFusion, a global medical device company, today announced an agreement to make bi-directional connectivity available between CareFusion's Alaris® System and Epic's electronic medical record (EMR) platform.

"This new relationship is an exciting step towards improving collaboration and connectivity between medical devices and information technology," said Darren Dworkin, senior vice president for Enterprise Information Systems and chief information officer at Cedars-Sinai Health System, a large academic medical center consistently ranked among the top hospitals in the nation. "This type of integration helps to further transform HIT into a strategic tool to drive improvements to both patient care and safety."

The companies intend to develop bi-directional capabilities to enable clinicians to remotely pre-populate infusion orders from the EMR to the Alaris® System, helping hospitals reduce the risk of harmful and costly intravenous (IV) medication errors that can occur during manual programming at the patient's bedside. This enhanced interface is being developed to help health care providers improve clinician workflow and increase efficiency by reducing manual or duplicative documentation that can occur through disparate systems.

"In the evolving health care landscape, interoperability between devices and information systems is among our customers' most critical priorities," said J.C. Kyrillos, senior vice president and general manager of CareFusion's Infusion Systems business. "This agreement with Epic builds on recent progress we have made across CareFusion to improve device interoperability and represents yet another way CareFusion helps hospitals bridge the gap between medical devices and HIT systems."

About CareFusionCareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, Air Life™ and LTV® series ventilation and respiratory products, ChloraPrep® skin prep products, MedMined® services for data mining surveillance, Nicolet™ neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 14,000 people across its global operations. More information may be found at www.carefusion.com.

(Logo: http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO)

SOURCE CareFusion

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,502.69 115.11 0.75%
NASDAQ 3,521.58 19.46 0.56%
S&P 500 1,680.95 11.79 0.71%
US 10 Yr 1.988% +0.044

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs